Form 4: Select Medical Holdings Executive Chairman Robert Ortenzio Sells 50,000 Shares

Robert Ortenzio, Executive Chairman of Select Medical Holdings, sold 50,000 shares of common stock at an average price of $28.30 on March 8, 2024, according to a Form 4 filing with the SEC.

Summary

• Robert A. Ortenzio, the Executive Chairman of Select Medical Holdings Corporation, sold 50,000 shares of common stock on March 8, 2024.
• The shares were sold at a weighted average price of $28.30, with individual transaction prices ranging from $28.08 to $28.595.
• The sale was executed under a pre-arranged 10b5-1 trading plan adopted on December 9, 2022.
• Following the transaction, Ortenzio directly owns 6,739,668 shares of Select Medical Holdings Corporation.
• Ortenzio also indirectly owns shares through various trusts, including the Robert A. Ortenzio Descendants Trust (1,279,000 shares), the Rocco A. Ortenzio Separate Exempt Descendants Trust (3,804,805 shares), and several 2014 trusts for his children (280,415 shares each).

Sentiment

Score: 5

Explanation: The document is a standard SEC filing related to an insider stock sale. It doesn't inherently convey positive or negative sentiment, as the sale was pre-planned.

Industry Context

Insider transactions are routinely monitored by investors as they can provide signals, though not always definitive, about a company's prospects. A sale by an executive chairman is generally viewed with more scrutiny than sales by other insiders.

Stakeholder Impact

• The stock sale could have a minor negative impact on shareholder sentiment, although the existence of a 10b5-1 plan mitigates this concern.

Key Dates